Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06343831 · ClinicalTrials.gov registry record · NA
Quantitative Assessment of Autologous Fat Transfer
A NA study of Autologous Fat Grafting, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT06343831: Recruiting NA study of Autologous Fat Grafting, sponsored by University of Chicago.
NCT06343831 is a NA study of Autologous Fat Grafting that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06343831, a NA study of Autologous Fat Grafting, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a single-arm, prospective pilot study that will objectively assess outcomes in patients electively undergoing Autologous Fat Transfer (AFT) for breast or chest wall reconstruction. Patients planning to undergo autologous fat transfer for breast or chest wall reconstruction will be enrolled prospectively. Participants will undergo standard photographs (2-D imaging) of their chest wall and torso, including the breasts, and complete a validated questionnaire (BREAST-QTM) to evaluate patient satisfaction, and quality of life, all standard of care. The 3D photographs, Magnetic resonance imaging (MRI), and Ultrasound (US) are routinely used in practice but will be performed for research purposes in this study. All imaging procedures and questionnaires will be obtained at baseline and follow-up visits 3-6.
Primary Outcome
Images will be obtained from photographs, ultrasound, and MRI to compare and follow outcomes of autologous fat grafting to the chest for reconstruction and to visualize changes in the breast over time.
Conditions Studied
Interventions
- PROCEDURE 2-Dimensional (2-D) Photographs (Visit 1/ Follow up Visit 3-6)
- PROCEDURE 3-Dimensional (3-D) Photographs (Visit 1- 6)
- PROCEDURE Ultrasound Soft Tissue Assessment (Visit 1/ Follow up Visit 4-6)
- PROCEDURE Magnetic Resonance Imaging Volume Assessment (Visit 1/ Follow up Visit 4-6)
- PROCEDURE BREAST-QTM questionnaire (Visit 1/ Follow up Visit 4-6)
Study Locations (2)
Illinois
- The University of Chicago - Chicago
Texas
- The University of Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-01-25 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06343831 shows while recruiting
NCT06343831 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Autologous Fat Grafting appearing as the primary indexed condition, and to 5 interventions - of which 2-Dimensional (2-D) Photographs (Visit 1/ Follow up Visit 3-6) is the first listed.
NCT06343831 reports a single indexed study location in Illinois, Texas.
Frequently Asked Questions
What is clinical trial NCT06343831 about?
NCT06343831 is a clinical study titled "Quantitative Assessment of Autologous Fat Transfer". This is a single-arm, prospective pilot study that will objectively assess outcomes in patients electively undergoing Autologous Fat Transfer (AFT) for breast or chest wall reconstruction. Patients planning to undergo autologous fat transfer for breast or chest wall reconstruction will be enrolled p...
What is the current status of trial NCT06343831?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-01-25. Estimated completion is 2026-12.
What conditions does trial NCT06343831 study?
This clinical trial studies the following conditions: Autologous Fat Grafting.
What interventions are being tested in trial NCT06343831?
The interventions under investigation include: 2-Dimensional (2-D) Photographs (Visit 1/ Follow up Visit 3-6) (PROCEDURE), 3-Dimensional (3-D) Photographs (Visit 1- 6) (PROCEDURE), Ultrasound Soft Tissue Assessment (Visit 1/ Follow up Visit 4-6) (PROCEDURE), Magnetic Resonance Imaging Volume Assessment (Visit 1/ Follow up Visit 4-6) (PROCEDURE), BREAST-QTM questionnaire (Visit 1/ Follow up Visit 4-6) (PROCEDURE).
Who is sponsoring clinical trial NCT06343831?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06343831 being conducted?
This trial has 2 study locations across Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06343831's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI